• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从收容中心看猫肥厚型心肌病的自然史:CatScan II 研究。

Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study.

机构信息

Clinical Science and Services, Royal Veterinary College, Hertfordshire, UK.

Langford Vets Small Animal Referral Hospital, University of Bristol, Bristol, UK.

出版信息

J Vet Intern Med. 2022 Nov;36(6):1900-1912. doi: 10.1111/jvim.16576. Epub 2022 Oct 31.

DOI:10.1111/jvim.16576
PMID:36315028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9708425/
Abstract

BACKGROUND

The natural history of hypertrophic cardiomyopathy (HCM) in cats has been mainly studied in cats referred for suspected heart disease, which can skew the results towards cats with clinical signs. Few data are available on factors associated with development of HCM in cats.

HYPOTHESES

(1) Clinical variables can predict which cats will develop HCM; (2) HCM in cats not referred for suspected heart disease is associated with a low rate of cardiovascular events.

ANIMALS

One hundred seven cats from rehoming centers without a history of clinical signs of cardiac or systemic disease at the time of adoption.

METHODS

Prospective longitudinal study. After rehoming, shelter cats were reexamined for serial echocardiograms. Cox regression analysis was used to identify predictors of development of HCM in cats that were normal at baseline. Adverse cardiovascular events including heart failure, thromboembolism, or sudden death were recorded.

RESULTS

Cats were monitored for a median of 5.6 [1.2-9.2] years. At baseline, 68/107 cats were normal, 18/107 were equivocal and 21/107 had HCM. Nineteen cats developed HCM during the study period. The factors at baseline associated with increased hazard of developing HCM were lower left atrial fractional shortening, higher left ventricular fractional shortening, and higher body weight. Cardiovascular events were observed in 21% of cats with HCM.

CONCLUSIONS AND CLINICAL IMPORTANCE

Cardiovascular events were common in cats with HCM from a rehoming center study sample. Lower left atrial systolic function appears to precede overt HCM.

摘要

背景

猫肥厚型心肌病(HCM)的自然病史主要在因疑似心脏病就诊的猫中进行研究,这可能导致结果偏向于有临床症状的猫。关于与猫 HCM 发展相关的因素,仅有少量数据。

假说

(1)临床变量可预测哪些猫会发生 HCM;(2)未因疑似心脏病就诊的猫的 HCM 与心血管事件发生率低有关。

动物

107 只来自收容所的猫,在领养时没有心脏病或全身性疾病的临床症状史。

方法

前瞻性纵向研究。在领养后,对收容所的猫进行了一系列超声心动图复查。使用 Cox 回归分析来确定基线正常的猫发生 HCM 的预测因素。记录了包括心力衰竭、血栓栓塞或猝死在内的不良心血管事件。

结果

猫的监测中位数为 5.6 [1.2-9.2] 年。基线时,107 只猫中有 68 只是正常的,18 只是不确定的,21 只是 HCM。在研究期间,19 只猫患上了 HCM。与发生 HCM 的风险增加相关的基线因素包括左心房分数缩短率较低、左心室分数缩短率较高和体重较高。21%的 HCM 猫出现了心血管事件。

结论和临床意义

在收容所研究样本中,患有 HCM 的猫常见心血管事件。左心房收缩功能降低似乎先于明显的 HCM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/02b92f9d5c07/JVIM-36-1900-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/da81e16c0372/JVIM-36-1900-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/115bb7bc9ebb/JVIM-36-1900-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/305961d018cb/JVIM-36-1900-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/4590463d0804/JVIM-36-1900-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/02b92f9d5c07/JVIM-36-1900-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/da81e16c0372/JVIM-36-1900-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/115bb7bc9ebb/JVIM-36-1900-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/305961d018cb/JVIM-36-1900-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/4590463d0804/JVIM-36-1900-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b7/9708425/02b92f9d5c07/JVIM-36-1900-g002.jpg

相似文献

1
Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study.从收容中心看猫肥厚型心肌病的自然史:CatScan II 研究。
J Vet Intern Med. 2022 Nov;36(6):1900-1912. doi: 10.1111/jvim.16576. Epub 2022 Oct 31.
2
Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.自发性肥厚型心肌病患宠的急性药效动力学研究
BMC Vet Res. 2021 Feb 23;17(1):89. doi: 10.1186/s12917-021-02799-9.
3
Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study).780只待领养中心的表面健康猫的心肌病患病率(猫扫描研究)
J Vet Cardiol. 2015 Dec;17 Suppl 1:S244-57. doi: 10.1016/j.jvc.2015.03.008.
4
The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.猫心肌病:2. 肥厚型心肌病。
J Feline Med Surg. 2021 Nov;23(11):1028-1051. doi: 10.1177/1098612X211020162.
5
Prognostic indicators in cats with hypertrophic cardiomyopathy.肥厚型心肌病猫的预后指标。
J Vet Intern Med. 2013 Nov-Dec;27(6):1427-36. doi: 10.1111/jvim.12215. Epub 2013 Oct 17.
6
Assessment of left atrial function in feline hypertrophic cardiomyopathy by using two- dimensional speckle tracking echocardiography.应用二维斑点追踪超声心动图评估猫肥厚型心肌病的左心房功能。
BMC Vet Res. 2020 Sep 18;16(1):344. doi: 10.1186/s12917-020-02557-3.
7
Anterior mitral valve leaflet length in cats with hypertrophic cardiomyopathy.猫肥厚型心肌病二尖瓣前叶长度。
J Vet Cardiol. 2021 Oct;37:62-70. doi: 10.1016/j.jvc.2021.09.001. Epub 2021 Sep 15.
8
Left atrial fractional shortening in cats: a comparison between two echocardiographic views.猫的左心房分数缩短率:两种超声心动图切面的比较。
J Vet Cardiol. 2024 Oct;55:38-47. doi: 10.1016/j.jvc.2024.08.002. Epub 2024 Aug 13.
9
Mitral Annular Plane Systolic Excursion and Tricuspid Annular Plane Systolic Excursion in Cats with Hypertrophic Cardiomyopathy.肥厚型心肌病猫的二尖瓣环平面收缩期位移和三尖瓣环平面收缩期位移
J Vet Intern Med. 2017 May;31(3):691-699. doi: 10.1111/jvim.14697. Epub 2017 Mar 30.
10
Assessment of left ventricular systolic function by strain imaging echocardiography in various stages of feline hypertrophic cardiomyopathy.应变成像超声心动图评估不同阶段猫肥厚型心肌病的左心室收缩功能。
J Vet Intern Med. 2010 Nov-Dec;24(6):1375-82. doi: 10.1111/j.1939-1676.2010.0586.x. Epub 2010 Aug 24.

引用本文的文献

1
Integrated MicroRNA-mRNA Sequencing Analysis Identifies Regulators and Networks Involved in Feline Hypertrophic Cardiomyopathy.整合的微小RNA-信使核糖核酸测序分析鉴定出参与猫肥厚性心肌病的调控因子和网络。
Int J Mol Sci. 2025 Jul 15;26(14):6764. doi: 10.3390/ijms26146764.
2
Selected Pathway Analyses to Gain Mechanistic Insights into the Pathogenesis of Feline Hypertrophic Cardiomyopathy.选择通路分析以深入了解猫肥厚性心肌病发病机制的机理
Int J Mol Sci. 2025 Jul 5;26(13):6497. doi: 10.3390/ijms26136497.
3
Clinical-Diagnostic and Therapeutic Advances in Feline Hypertrophic Cardiomyopathy.

本文引用的文献

1
Atrial Mechanics in Hypertrophic Cardiomyopathy: Discriminating between Ventricular Hypertrophy and Fibrosis.肥厚型心肌病中的心房力学:区分心室肥厚与纤维化。
Arq Bras Cardiol. 2022 Jan;118(1):77-87. doi: 10.36660/abc.20200890.
2
Anterior mitral valve leaflet length in cats with hypertrophic cardiomyopathy.猫肥厚型心肌病二尖瓣前叶长度。
J Vet Cardiol. 2021 Oct;37:62-70. doi: 10.1016/j.jvc.2021.09.001. Epub 2021 Sep 15.
3
Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy.猫的临床前肥厚型心肌病的细胞外容积分数。
猫肥厚性心肌病的临床诊断与治疗进展
Vet Sci. 2025 Mar 19;12(3):289. doi: 10.3390/vetsci12030289.
4
Prevalence of Hypertrophic Cardiomyopathy and ALMS1 Variant in Sphynx Cats in New Zealand.新西兰无毛猫肥厚型心肌病及ALMS1变异的患病率
Animals (Basel). 2024 Sep 10;14(18):2629. doi: 10.3390/ani14182629.
5
The Unseen Side of Feline Hypertrophic Cardiomyopathy: Diagnostic and Prognostic Utility of Electrocardiography and Holter Monitoring.猫肥厚性心肌病的隐匿面:心电图和动态心电图监测的诊断及预后价值
Animals (Basel). 2024 Jul 25;14(15):2165. doi: 10.3390/ani14152165.
6
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy.肌球蛋白抑制剂 CK-586 可轻微降低收缩功能并改善猫肥厚型心肌病的梗阻。
Sci Rep. 2024 May 27;14(1):12038. doi: 10.1038/s41598-024-62840-3.
7
Influence of Clinical Aspects and Genetic Factors on Feline HCM Severity and Development.临床因素和遗传因素对猫肥厚型心肌病严重程度及发展的影响
Vet Sci. 2024 May 13;11(5):214. doi: 10.3390/vetsci11050214.
8
The effect of obesity and subsequent weight reduction on cardiac morphology and function in cats.肥胖及随后的体重减轻对猫心脏形态和功能的影响。
BMC Vet Res. 2024 Apr 24;20(1):154. doi: 10.1186/s12917-024-04011-0.
J Vet Intern Med. 2021 Mar;35(2):812-822. doi: 10.1111/jvim.16067. Epub 2021 Feb 26.
4
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.马卡丹特治疗有症状梗阻性肥厚型心肌病(EXPLORER-HCM)的随机、双盲、安慰剂对照、3 期临床试验
Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29.
5
Risk indictors in cats with preclinical hypertrophic cardiomyopathy: a prospective cohort study.临床前期肥厚型心肌病猫的风险指标:一项前瞻性队列研究。
J Feline Med Surg. 2021 Feb;23(2):149-159. doi: 10.1177/1098612X20938651. Epub 2020 Jul 22.
6
ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats.ACVIM 共识声明指南:猫心肌病的分类、诊断和管理。
J Vet Intern Med. 2020 May;34(3):1062-1077. doi: 10.1111/jvim.15745. Epub 2020 Apr 3.
7
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.无左心室肥厚的肥厚型心肌病的临床病程及意义
Circulation. 2019 Feb 5;139(6):830-833. doi: 10.1161/CIRCULATIONAHA.118.037264.
8
Hypertrophic Cardiomyopathy.肥厚型心肌病
Circulation. 2018 Oct 2;138(14):1399-1401. doi: 10.1161/CIRCULATIONAHA.118.035932.
9
International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.评估临床前肥厚型心肌病猫和明显健康猫的心血管风险及评估长期健康状况的国际合作研究:REVEAL研究。
J Vet Intern Med. 2018 May;32(3):930-943. doi: 10.1111/jvim.15122. Epub 2018 Apr 16.
10
Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.肥厚型心肌病肌节突变携带者左心房结构和功能与左心室肥厚的关系。
J Cardiovasc Magn Reson. 2017 Dec 28;19(1):107. doi: 10.1186/s12968-017-0420-0.